424 related articles for article (PubMed ID: 19689543)
21. Designing a treatment protocol with voriconazole to eliminate Aspergillus fumigatus from experimentally inoculated pigeons.
Beernaert LA; Pasmans F; Baert K; Van Waeyenberghe L; Chiers K; Haesebrouck F; Martel A
Vet Microbiol; 2009 Nov; 139(3-4):393-7. PubMed ID: 19574001
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous aspergillosis in a lung transplant recipient.
Ramos A; Ussetti P; Laporta R; Lázaro MT; Sánchez-Romero I
Transpl Infect Dis; 2009 Oct; 11(5):471-3. PubMed ID: 19622116
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of invasive aspergillosis with oral voriconazole following intravenous liposomal amphotericin in a child with acute lymphoblastic leukemia.
Lassaletta A; Perez A; Díaz MA; Sevilla J; González-Vicent M; Madero L
J Pediatr Hematol Oncol; 2004 Feb; 26(2):117-9. PubMed ID: 14767202
[No Abstract] [Full Text] [Related]
24. Successful treatment of primary cutaneous Aspergillus ustus infection with surgical debridement and a combination of voriconazole and terbinafine.
Krishnan-Natesan S; Chandrasekar PH; Manavathu EK; Revankar SG
Diagn Microbiol Infect Dis; 2008 Dec; 62(4):443-6. PubMed ID: 18842377
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of oral voriconazole in patients with cystic fibrosis.
Clifton IJ; Whitaker P; Metcalfe R; Phillip M; Shaw N; Conway SP; Peckham DG
J Antimicrob Chemother; 2011 Oct; 66(10):2438-40. PubMed ID: 21791443
[No Abstract] [Full Text] [Related]
26. Management of Aspergillus osteomyelitis: report of failure of liposomal amphotericin B and response to voriconazole in an immunocompetent host and literature review.
Stratov I; Korman TM; Johnson PD
Eur J Clin Microbiol Infect Dis; 2003 May; 22(5):277-83. PubMed ID: 12734721
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous aspergillosis in a patient with cutaneous T-cell lymphoma.
Yuanjie Z; Jingxia D; Hai W; Jianghan C; Julin G
Mycoses; 2009 Sep; 52(5):462-4. PubMed ID: 18983429
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment of an Aspergillus fumigatus Infection with voriconazole via a nasogastric tube.
Grau S; Mateu-De AJ; Alvarez-Lerma F; Marín-Casino M; Torres-Rodríguez JM
J Chemother; 2006 Aug; 18(4):445-6. PubMed ID: 17024806
[No Abstract] [Full Text] [Related]
29. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
Pascual A; Calandra T; Bolay S; Buclin T; Bille J; Marchetti O
Clin Infect Dis; 2008 Jan; 46(2):201-11. PubMed ID: 18171251
[TBL] [Abstract][Full Text] [Related]
30. [Update on voriconazole].
Dtsch Med Wochenschr; 2003 Aug; 128(33):1738. PubMed ID: 12968630
[No Abstract] [Full Text] [Related]
31. Treatment of primary aspergilloma of the central nervous system in a diabetic immunocompetent patient with surgical resection and voriconazole: a case report and review of the literature.
Koshy R; Malhotra P
Turk Neurosurg; 2011; 21(4):641-4. PubMed ID: 22194129
[TBL] [Abstract][Full Text] [Related]
32. Primary Cutaneous Aspergillosis in a Preterm Infant.
Frick MA; Boix H; Camba Longueira F; Martin-Gomez MT; Rodrigo-Pendás JÁ; Soler-Palacin P
Pediatr Infect Dis J; 2016 Jun; 35(6):704-6. PubMed ID: 26974892
[TBL] [Abstract][Full Text] [Related]
33. Radiological resolution of cavitating Aspergillus fumigatus infection following treatment with oral voriconazole in two lung transplant recipients.
Zoumot Z; Carby M; Hall AV
Transpl Int; 2006 Aug; 19(8):688-90. PubMed ID: 16827687
[No Abstract] [Full Text] [Related]
34. Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
Przepiorka D; Buadi FK; McClune B
Pharmacotherapy; 2008 Jan; 28(1):58-63. PubMed ID: 18154475
[TBL] [Abstract][Full Text] [Related]
35. Disseminated cutaneous phaeohyphomycosis in immunocompetent child.
Mudholkar VG; Acharya AS; Ramteke RV
Pediatr Dermatol; 2011; 28(1):30-1. PubMed ID: 21261701
[TBL] [Abstract][Full Text] [Related]
36. Importance of voriconazole therapeutic drug monitoring in pediatric cancer patients with invasive aspergillosis.
Choi SH; Lee SY; Hwang JY; Lee SH; Yoo KH; Sung KW; Koo HH; Kim YJ
Pediatr Blood Cancer; 2013 Jan; 60(1):82-7. PubMed ID: 22887791
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus successfully treated by oral voriconazole and nystatin packing.
Huang CY; Sun PL; Tseng HK
Mycopathologia; 2011 Aug; 172(2):141-5. PubMed ID: 21424606
[TBL] [Abstract][Full Text] [Related]
38. Use of oral voriconazole as adjunctive treatment of severe cornea fungal infection: case report.
Freda R
Arq Bras Oftalmol; 2006; 69(3):431-4. PubMed ID: 16936973
[TBL] [Abstract][Full Text] [Related]
39. Utilisation, efficacy and safety of voriconazole: prospective, non-interventional study on treatment of IFIs in clinical practice.
Heinz WJ; Silling G; Böhme A
Curr Med Res Opin; 2011 Feb; 27(2):335-42. PubMed ID: 21155707
[TBL] [Abstract][Full Text] [Related]
40. Unusual case of cutaneous and synovial Paecilomyces lilacinus infection of hand successfully treated with voriconazole and review of published literature.
Keshtkar-Jahromi M; McTighe AH; Segalman KA; Fothergill AW; Campbell WN
Mycopathologia; 2012 Sep; 174(3):255-8. PubMed ID: 22484831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
